Skip to content
★ Sign in to follow
JL

Jane Lebkowski

Executive
Asterias Biotherapeutics, Inc.Geron Corp
Total declarations
40
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (10 ops.)
€386k

Latest filing published 07 Jun 2017 for Asterias Biotherapeutics, Inc., €20k.

Insider track record

Disclosed buys
0
Disclosed sells
10
Signal history

No signal scores available.

Jane Lebkowski: trading record in brief

Jane Lebkowski discloses dealings in 2 companies, chiefly Geron Corp and Asterias Biotherapeutics, Inc. Over a trading history stretching from 6 January 2006 to 5 June 2017, the count stands at 40 filings.

Every open-market trade on record is a sale: 10 sales worth €386k. Other entries cover 24 share grants.

The newest entry dates from 7 June 2017: a share grant of €20k, in Asterias Biotherapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Jane Lebkowski

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations34 total

25 of 34 declarations